Application 087197
- Type
- ANDA
- Sponsor
- WATSON LABS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SULFASALAZINE | SULFASALAZINE | TABLET;ORAL | 500MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A087197-001 | SULFASALAZINE | SULFASALAZINE | 500MG | TABLET / ORAL | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A087197-001 | SULFASALAZINE | 500MG | TABLET / ORAL | Approved before 1982 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A087197-001 | SULFASALAZINE | 500MG | TABLET / ORAL | Approved before 1982 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A087197-001 | SULFASALAZINE | 500MG | TABLET / ORAL | Approved before 1982 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A087197-001 | SULFASALAZINE | 500MG | TABLET / ORAL | Approved before 1982 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sulfasalazine | SULFASALAZINE | Mylan Pharmaceuticals Inc. | 257cee60-b68f-4c2b-b57d-8e4d73d17e09 | 2026-08-25 | Warnings, Adverse reactions | Sulfasalazine SULFASALAZINE |
| Sulfasalazine | SULFASALAZINE | Mylan Pharmaceuticals Inc. | 48fbc535-a33a-45ee-85ff-9d1ec9b31d9c | 2026-08-25 | Warnings, Adverse reactions | Sulfasalazine SULFASALAZINE |
| Azulfidine | SULFASALAZINE | Pfizer Laboratories Div Pfizer Inc | ddbe69f3-bd55-45f3-a64f-f60226c744c4 | 2026-05-29 | Warnings, Adverse reactions | SULFASALAZINE |
| Azulfidine EN-tabs | SULFASALAZINE | Pfizer Laboratories Div Pfizer Inc | b9ef541a-93c8-4428-ba45-398aa0b327d1 | 2026-05-29 | Warnings, Adverse reactions | SULFASALAZINE |
| Sulfasalazine | SULFASALAZINE | Sunrise Pharmaceutical, Inc. | d596ac59-b643-4181-80ba-f2db1cc3459c | 2025-12-11 | Warnings, Adverse reactions | Sulfasalazine SULFASALAZINE |
| Sulfasalazine | SULFASALAZINE | Rising Pharma Holdings, Inc. | 3254432e-87a4-4af0-afd1-d9e6f1b0efd4 | 2025-11-06 | Warnings, Adverse reactions | Sulfasalazine SULFASALAZINE |
| Sulfasalazine | SULFASALAZINE | Sunrise Pharmaceutical, Inc. | a54b31cc-205d-43d3-a850-acf4b41fbc37 | 2025-09-15 | Warnings, Adverse reactions | Sulfasalazine SULFASALAZINE |
| Sulfasalazine | SULFASALAZINE | A-S Medication Solutions | 76b532a3-e7ca-4929-8c51-c0f66e0806a8 | 2025-04-08 | Warnings, Adverse reactions | Sulfasalazine SULFASALAZINE |
| Sulfasalazine | SULFASALAZINE | A-S Medication Solutions | 32fd1726-ed81-4441-9594-3aecf2db1dbf | 2025-04-08 | Warnings, Adverse reactions | Sulfasalazine SULFASALAZINE |
| Sulfasalazine | SULFASALAZINE | Bryant Ranch Prepack | 618c5324-d0a6-4d00-9b12-0de88a71c180 | 2024-04-04 | Warnings, Adverse reactions | Sulfasalazine SULFASALAZINE |
| Sulfasalazine | SULFASALAZINE | Teva Pharmaceuticals USA, Inc. | 3c59593b-e1a5-47cb-a82b-3e5e49205344 | 2023-08-22 | Warnings, Adverse reactions | Sulfasalazine SULFASALAZINE |
| Sulfasalazine | SULFASALAZINE | Aphena Pharma Solutions - Tennessee, LLC | bf5137fe-60ed-4497-8521-eeb0a684fabf | 2023-05-16 | Warnings, Adverse reactions | Sulfasalazine SULFASALAZINE |
| Sulfasalazine | SULFASALAZINE | Chartwell RX, LLC. | 029716bd-ee1a-484c-bf1f-ec8d02d5281b | 2022-12-12 | Warnings, Adverse reactions | Sulfasalazine SULFASALAZINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 68788-9021 | SULFASALAZINE | SULFASALAZINE | Preferred Pharmaceuticals | ANDA | Current |
| 68788-9021 | SULFASALAZINE | SULFASALAZINE | Preferred Pharmaceuticals, Inc | ANDA | Current |